These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9803621)

  • 1. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course instead of long-course chemotherapy for smear-negative patients in sub-Saharan Africa.
    van Gorkom J; van Cleeff M; Becx-Bleumink M; Veen J
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):4-11. PubMed ID: 11263514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa.
    Harries AD; Hargreaves NJ; Kumwenda J; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):998-1001. PubMed ID: 11092710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
    Harries AD; Hargreaves NJ; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1109-15. PubMed ID: 11769768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D; Harries A; Getahun H
    Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HIV on tuberculosis in sub-Saharan Africa: a regional perspective.
    Cantwell MF; Binkin NJ
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):205-14. PubMed ID: 9432365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculosis and the HIV pandemic. Risk of nosocomial tuberculosis infection].
    Pedersen C; Kolmos HJ; Nielsen JO
    Ugeskr Laeger; 1997 Feb; 159(9):1233-8. PubMed ID: 9072866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic review: tuberculosis.
    Houston S; Pozniak A; Ray CS
    Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.
    Harries AD; Maher D; Nunn P
    Bull World Health Organ; 1998; 76(6):651-62. PubMed ID: 10191561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
    De Cock KM; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):457-65. PubMed ID: 10383056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated Kaposi sarcoma in African children.
    Feller L; Khammissa RA; Gugushe TS; Chikte UM; Wood NH; Meyerov R; Lemmer J
    SADJ; 2010 Feb; 65(1):20-2. PubMed ID: 20411798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].
    Anglaret X
    Med Trop (Mars); 2006 Aug; 66(4):343-5. PubMed ID: 16999042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD; Maher D; Nunn P
    Bull World Health Organ; 1997; 75(5):477-89. PubMed ID: 9447782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
    Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The resurgence of tuberculosis.
    Parry C; Davies PD
    Soc Appl Bacteriol Symp Ser; 1996; 25():23S-26S. PubMed ID: 8972116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.